Eton Pharmaceuticals (ETON) Change in Accured Expenses (2019 - 2025)
Eton Pharmaceuticals (ETON) has disclosed Change in Accured Expenses for 7 consecutive years, with $426000.0 as the latest value for Q4 2025.
- Quarterly Change in Accured Expenses fell 79.15% to $426000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, down 31.87% year-over-year, with the annual reading at $1.0 million for FY2025, 31.87% down from the prior year.
- Change in Accured Expenses hit $426000.0 in Q4 2025 for Eton Pharmaceuticals, down from $1.8 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $2.0 million in Q4 2024 to a low of -$1.6 million in Q1 2024.
- Historically, Change in Accured Expenses has averaged $326850.0 across 5 years, with a median of $397000.0 in 2021.
- Biggest five-year swings in Change in Accured Expenses: skyrocketed 4230.0% in 2023 and later crashed 232.28% in 2024.
- Year by year, Change in Accured Expenses stood at $120000.0 in 2021, then tumbled by 153.33% to -$64000.0 in 2022, then skyrocketed by 2246.88% to $1.4 million in 2023, then soared by 48.69% to $2.0 million in 2024, then tumbled by 79.15% to $426000.0 in 2025.
- Business Quant data shows Change in Accured Expenses for ETON at $426000.0 in Q4 2025, $1.8 million in Q3 2025, and $172000.0 in Q2 2025.